The need for laparoscopic devices is predicted to rise at a sluggish CAGR of 4.2% through 2034. The industry is projected to surpass USD 20.5 billion by 2034. The surge in the prevalence of obesity ...

The global sales of rare neurological disease treatment is estimated to be worth USD 19.95 billion in 2025 and anticipated to reach a value of USD 40.67 billion by 2035. Sales are projected to rise at ...

The Rare Inflammatory Disease Treatment Market has garnered a market value of USD 12,664 Million in 2021, anticipated to register a positive CAGR of 4.6% in the forecast period 2022 to 2028 and reach ...

The global cellulite treatment market is expected to be valued at USD 3.67 billion in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period from 2024 to 2034, eventually exceeding ...

The 3D printed medical devices market is an emerging sector reshaping the healthcare landscape through advanced manufacturing technologies. By enabling precise customization, rapid prototyping, and ...

The Molecular Biology Enzymes, Kits & Reagents Market plays a pivotal role in advancing scientific research and biotechnology development globally. These products form the backbone of molecular ...

The on-site preventive care market is to be valued at USD 26.21 billion in 2024. The market is slated to rise at a CAGR of 5.2% from 2024 to 2034. A market valuation of USD 43.52 billion is expected ...

The global sales of anaesthesia machines is estimated to be worth USD 11.1 billion in 2024 and anticipated to reach a value of USD 17.7 billion by 2034. Sales are projected to rise at a CAGR of 4.8% ...

The surface plasmon resonance market has gained significant attention in recent years due to its crucial role in biosensing, diagnostics, and drug discovery. Surface plasmon resonance (SPR) technology ...

The global sales of disposable negative pressure wound therapy devices are estimated to be worth USD 287.5 million in 2024 and are anticipated to reach a value of USD 529.7 million by 2034. Sales are ...

The global market for Genital Herpes Treatment is forecasted to attain USD 2,334.1 million by 2025, expanding at 4.9% CAGR to reach USD 3,772.1 million by 2035. In 2024, the revenue of Genital Herpes ...

Increasing demand for non-invasive biomarkers to catapult growth in the exosome diagnostic and therapeutic market. The market size is expected to increase from USD 88.56 million in 2024 to USD 211.6 ...